ÖZKAN, G. Et Al. 2013. Thrombin activatable fibrinolysis inhibitor (TAFI) levels in hypertensive patients and a comparison of the effects of amlodipine and ramipril on TAFI levels. CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.35 , 134-140.

ÖZKAN, G., ULUSOY, Ş., SÖNMEZ, M., KARAHAN, S. C., MENTEŞE, A., KAYNAR, R. K., ... BEKTAŞ, Ö.(2013). Thrombin activatable fibrinolysis inhibitor (TAFI) levels in hypertensive patients and a comparison of the effects of amlodipine and ramipril on TAFI levels. CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.35, 134-140.

ÖZKAN, GÜLSÜM Et Al. "Thrombin activatable fibrinolysis inhibitor (TAFI) levels in hypertensive patients and a comparison of the effects of amlodipine and ramipril on TAFI levels," CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.35, 134-140, 2013

ÖZKAN, GÜLSÜM Et Al. "Thrombin activatable fibrinolysis inhibitor (TAFI) levels in hypertensive patients and a comparison of the effects of amlodipine and ramipril on TAFI levels." CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.35, pp.134-140, 2013

ÖZKAN, G. Et Al. (2013) . "Thrombin activatable fibrinolysis inhibitor (TAFI) levels in hypertensive patients and a comparison of the effects of amlodipine and ramipril on TAFI levels." CLINICAL AND EXPERIMENTAL HYPERTENSION , vol.35, pp.134-140.

@article{article, author={GÜLSÜM ÖZKAN Et Al. }, title={Thrombin activatable fibrinolysis inhibitor (TAFI) levels in hypertensive patients and a comparison of the effects of amlodipine and ramipril on TAFI levels}, journal={CLINICAL AND EXPERIMENTAL HYPERTENSION}, year=2013, pages={134-140} }